Feng Chi Biotech

Feng Chi Biotech Quick Ratio

The Quick Ratio (Acid Test) of Feng Chi Biotech (6744.TWO) as of Nov 3, 2026 is 0.03. In the previous year, Quick Ratio (Acid Test) was 4.05 — a change of -99.21% (lower).

Quick Ratio

0.03

YoY

-99.21%

Last updated:

Quick Ratio (Acid Test) of Feng Chi Biotech is 2025 0.03 . Quick Ratio (Acid Test) of Feng Chi Biotech was 2024 4.05 . It decreases by -99.21% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Feng Chi Biotech Stock analysis

What does Feng Chi Biotech do? Feng Chi Biotech Corp. generates revenue through the sale of prenatal and neonatal testing reagents and instruments, genetic testing analysis and development services, research instruments and reagents, and industrial microbiology and food testing reagents. The company's products are primarily sold to markets in Taiwan, China mainland, Japan, South Korea, Southeast Asia, and India, as well as other overseas regions. These services and products target healthcare providers, research institutions, and food safety regulators within these regions. The firm focuses on delivering comprehensive testing solutions across life science and microbiological applications for both clinical and industrial use cases. The company's product portfolio includes specialized reagents and instruments for prenatal and newborn screening, genetic analysis, and microbiological testing. These offerings are tailored to meet the needs of healthcare facilities and laboratories in the specified geographic markets. By providing end-to-end testing services and equipment, Feng Chi Biotech Corp. serves the growing demand for accurate diagnostic tools in reproductive health, genetic research, and food safety sectors. Feng Chi Biotech Corp. operates within the life science and microbiological testing services sector, offering a range of products that support prenatal care, neonatal screening, genetic research, and industrial food testing. The company's international sales strategy targets key regions in Asia, including Taiwan, China mainland, Japan, South Korea, Southeast Asia, and India, where healthcare and food safety regulations require regular testing. Their business model centers on providing reliable diagnostic solutions to medical and industrial clients across these markets. Feng Chi Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Feng Chi Biotech stock

Quick Ratio (Acid Test) of Feng Chi Biotech is 0.03 in 2025.

Quick Ratio (Acid Test) of Feng Chi Biotech changed from 4.05 to 0.03, representing a -99.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Feng Chi Biotech since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Feng Chi Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Feng Chi Biotech

All Key Metrics — Feng Chi Biotech